Dhanuka Agritech reported a healthy Q2 FY27 performance with revenue growing nearly 10% to Rs 657.51 crore and PAT reaching Rs 109.22 crore. Despite this growth, management issued a cautious full-year outlook, citing tepid demand and projected margin compression due to pricing pressures in the generic segment. Investors are focused on the upcoming Rabi season performance and the continued operational ramp-up at the Dahej facility.
Dhanuka Agritech Q2 Profit Rises to Rs 109 Crore
Revenue for Q2 FY27 stood at Rs 657.51 crore, with Profit After Tax at Rs 109.22 crore.
Reader Takeaway: Strong quarterly growth is offset by management's cautious outlook on margins and generic pricing pressures ahead.
What just happened
Dhanuka Agritech posted a steady performance for the second quarter of the fiscal year. Revenue increased by 9.91% year-on-year to Rs 657.51 crore. Profit After Tax grew to Rs 109.22 crore, up from Rs 93.97 crore in the same period last year. EBITDA also saw an uptick, reaching Rs 152.97 crore. Insecticides remain the primary growth engine, contributing 47% to the total revenue mix.
Why this matters
The company managed to navigate a challenging monsoon period by leveraging demand in irrigated regions. Operational efficiency and cost management helped drive the bottom-line growth. However, management has signaled that the remainder of the year may be difficult. They have provided a 'low single-digit' revenue growth guidance for the full year, citing a broader slowdown in industry demand.
Risks to watch
Investors should pay close attention to margin sustainability. Management expects a gross margin compression of approximately 100 basis points in future periods. This is attributed to persistent pricing pressure in the generic product segment and the inability to fully pass on rising raw material costs to end consumers. The company's performance for the second half of the fiscal year is heavily dependent on the success of the upcoming Rabi season, particularly in the South and East regions.
Operational updates
The company continues to focus on maintaining a lean supply chain, with zero channel stuffing reported. The Dahej manufacturing plant is currently producing two items, with plans to scale up to four products by FY28. Management noted that EBITDA losses at this facility have narrowed significantly during the first half of the year, which remains a positive for long-term margin improvement.